Seeking Alpha

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

IRVINE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...
Business Insider

Inari Medical Announces Completion of Patient Enrollment in the FLARE Study for the Treatment of Pulmonary Embolism

IRVINE, Calif., Oct. 24, 2017 /PRNewswire/ -- Inari Medical, Inc., a privately held venture backed medical device company dedicated to the development of innovative catheter-based technologies for the ...
Seeking Alpha

Inari Medical: Targeting Underpenetrated $5.8 Billion Thromboembolism Market

Inari Medical, Inc. (NARI) was founded in 2011 and is based in Irvine, California. The company is focused on treating venous thromboembolism by thrombectomy. The currently approved thrombectomy ...
Nasdaq

Inari Medical (NARI) Launches New Catheters to Address VTE

Inari Medical, Inc. NARI recently announced the commercial launch of two new purpose-built products, the RevCore thrombectomy catheter and the Triever16 Curve catheter. RevCore is currently the first ...
KLFY News 10

Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism Patients

IRVINE, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous ...
Business Insider

FlowTriever System from Inari Medical Receives FDA 510(k) Clearance for Treatment of Pulmonary Embolism

IRVINE, Calif., May 21, 2018 /PRNewswire/ -- Inari Medical, Inc., announced today the FlowTriever System has received FDA 510(k) clearance for the treatment of pulmonary embolism ("PE"). This ...